Table of Contents
Researchers from The University of Texas MD Anderson Cancer Center found that the nauseating procedure resolved severe colitis in two patients who developed the disease following cancer therapy.
Collaboration Combines CollPlants Proprietary rhCollagen-based BioInk Technology and United Therapeutics Regenerative Medicine and Organ Manufacturing Capabilities NESS ZIONA, Israel, November 12, 2018 -- (Healthcare Sales &Marketing Network) -- Col... Devices, Regenerative Medicine, Licensing CollPlant, United Therapeutics, Lung Biotechnology PBC, 3D bioprinting
A case study of two patients with advanced cancer shows it might be possible to avoid a common and severe side effect of immunotherapy treatment.
Authors: Majanović SK, Zelić M, Belančić A, Licul V, Vujičić B, Girotto N, Štimac D Abstract Diabetic gastroparesis (DGP), a delay in gastric emptying without obstruction to outflow as a complication of diabetes, typically develops after at least 10 years of diabetes. Cardinal symptoms include nausea, vomiting, early satiety, bloating, and upper abdominal pain. The aim of DGP treatment is to alleviate the severity and frequency of symptoms, improve the level of gastric emptying, ameliorate the patient's nutritional status and to optimize glycemic control. In the treatment of chronic drug-refractory nau...
ConclusionThere were an increase and a decrease in the number of Th17 and Treg cells, respectively, with Th17/Treg cells imbalanced in unexplained RIF. GnRHa downregulation may play a direct immunomodulatory role in disrupting the imbalance and then improve the endometrial receptivity. These effects did not depend on the E2 levels in peripheral blood, nor affect early embryonic development.
ConclusionsOur findings confirm that screening for AdV is more common in pediatric patients. Antiviral treatment is employed in both pediatric and adult patients, although adults are generally treated when AdV disease is diagnosed. The approach to AdV screening and treatment is risk ‐based and consistent with clinical guidelines.This article is protected by copyright. All rights reserved.
This article is protected by copyright. All rights reserved.
ConclusionsCombination of flow cytometry with BrdU or ki67/DAPI staining could become a standard for the determination of MM cell proliferation. Furthermore, in the context of new effective myeloma treatment options, assessment of MM cell proliferation may be valuable, in clinical trials, to identify novel agents that could significantly affect the small proliferative compartment of MM cells. © 2018 International Clinical Cytometry Society
Recipient BCL2 inhibition and NK cell ablation form part of a reduced intensity conditioning regime that improves allo-bone marrow transplantation outcomes, Published online: 12 November 2018; doi:10.1038/s41418-018-0228-yRecipient BCL2 inhibition and NK cell ablation form part of a reduced intensity conditioning regime that improves allo-bone marrow transplantation outcomes
AbstractObjectiveWe aim to analyze the trends in donor nephrectomy (DN) across three surgical disciplines —urology, general surgery, and transplant surgery, specifically to analyze the surgical techniques and perioperative outcomes.Materials and methodsWe reviewed all live DN reported in the Statewide Planning and Research Cooperative System database of New York State (NYS) from 1995 to 2015. Surgeons were grouped in their respective disciplines using their state license number and the American Medical Association masterfile. We analyzed the volume of DN performed by each group along with how the surgical approach...